Streamline Bio

Streamline Bio is solving critical challenges in cell and gene therapy (CGT) manufacturing process to make CGT accessible to patients in need. 𝗜𝗻 𝗖𝗚𝗧, end-to-end 𝗮𝘂𝘁𝗼𝗺𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗼𝗳𝘁𝗲𝗻 𝗵𝗮𝗶𝗹𝗲𝗱 𝗮𝘀 𝘁𝗵𝗲 “𝗵𝗼𝗹𝘆 𝗴𝗿𝗮𝗶𝗹”, the solution to all the manufacturing problems and bottlenecks. However, CGT processes are inherently complex, multi-step, and notoriously variable; this makes it extremely difficult to develop an one-size-fits-all automation solution. That’s where we come in. Streamline Bio offers an AI-driven robotics platform that not only automates but is designed to be flexible, machine-agnostic, and fully digital-native.